CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 90 enrolled
Drug / intervention
Glucose oxidase + glucose +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01883440
NCT01883440Phase 2Completed
CompareCT.gov

A Placebo Controlled Study With a Nasal Spray Containing Glucose Oxidase, Aiming to Induce a Faster Recovery From an Episode of Common Cold

Krister Tano·interventional·Posted Jun 21, 2013·Updated Jan 27, 2016

In Brief

A Phase 2 clinical trial evaluating Glucose oxidase + glucose and Saline+glucose for Common Cold. Completed, enrolled 90 participants across 1 site.

Detailed Summary

Glucose oxidase is a hydrogen peroxide producing enzyme, which also is present in honey. Human rhinoviruses are sensitive to the action of hydrogen peroxide, which is documented in laboratory studies. In the present study we aim to investigate if a nasal spray with glucose oxidase could treat a common cold, when the treatment is started even after the onset of the symptoms. The study is randomized and placebo controlled.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Cold
CountriesSweden
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 21, 2013
Enrollment StartJan 1, 2013
Primary CompletionAug 1, 2013
Study CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.0 years ago

Interventions

Glucose oxidase + glucosedrug

Isotone saline + 200U/ml of glucose oxidase + 5% of glucose in a bag on valve nasal spray device

Saline+glucosedrug

Placebo arm